kt 5823 has been researched along with adenosine-3',5'-cyclic phosphorothioate in 1 studies
Studies (kt 5823) | Trials (kt 5823) | Recent Studies (post-2010) (kt 5823) | Studies (adenosine-3',5'-cyclic phosphorothioate) | Trials (adenosine-3',5'-cyclic phosphorothioate) | Recent Studies (post-2010) (adenosine-3',5'-cyclic phosphorothioate) |
---|---|---|---|---|---|
317 | 0 | 59 | 507 | 0 | 47 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Deth, RC; Sharma, A; Waly, M | 1 |
1 other study(ies) available for kt 5823 and adenosine-3',5'-cyclic phosphorothioate
Article | Year |
---|---|
Protein kinase C regulates dopamine D4 receptor-mediated phospholipid methylation.
Topics: Alkaloids; Benzophenanthridines; Carbazoles; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cyclic GMP-Dependent Protein Kinases; Dopamine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Indoles; Methylation; Naphthalenes; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Nitroprusside; Phenanthridines; Phorbol 12,13-Dibutyrate; Phospholipids; Protein Kinase C; Receptors, Dopamine D2; Receptors, Dopamine D4; Thionucleotides; Tumor Cells, Cultured | 2001 |